Skip to main content
Normal View

Medicinal Products Reimbursement

Dáil Éireann Debate, Tuesday - 10 October 2017

Tuesday, 10 October 2017

Questions (302)

Josepha Madigan

Question:

302. Deputy Josepha Madigan asked the Minister for Health his plans to expand the licence for pembrolizumab to cover rare cancers (details supplied). [42530/17]

View answer

Written answers

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.

Top
Share